Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Allergan plc    AGN   IE00BY9D5467

ALLERGAN PLC

(AGN)
  Report  
Delayed Quote. Delayed Nyse - 09/13 06:30:00 pm
166.14 USD   -0.13%
09/13ALLERGAN : Form 8.3 - Allergan Plc
DJ
09/12ALLERGAN : Form 8.3 -
DJ
09/11UPDATE : Form 8.3 - Allergan Plc (Correction of Doc)
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

Allergan : Form 8.3 -

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/12/2019 | 10:27am EDT
TIDM0Y7T TIDM0QCV 
 
 
   FORM 8.3 
 
   IRISH TAKEOVER PANEL 
 
   DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, 
TAKEOVER RULES, 2013 
 
   DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 
1% OR MORE 
 
   1. KEY INFORMATION 
 
 
 
 
Name of person dealing (Note 1)                State Street Global Advisors & 
                                               Affiliates 
---------------------------------------------  ------------------------------- 
Company dealt in                               Allergan plc 
---------------------------------------------  ------------------------------- 
Class of relevant security to which            US$0.0001 ordinary shares 
 the dealings being disclosed relate (Note 2) 
---------------------------------------------  ------------------------------- 
Date of dealing                                11(th) September 2019 
---------------------------------------------  ------------------------------- 
 
 
 
   2. INTERESTS AND SHORT POSITIONS 
 
   (a) Interests and short positions (following dealing) in the class of 
relevant security dealt in (Note 3) 
 
 
 
 
                                               Long             Short 
-------------------------------------  --------------------  ----------- 
                                         Number      (%)     Number  (%) 
-------------------------------------  ----------  --------  ------  --- 
(1) Relevant securities                15,065,388  4.59557% 
-------------------------------------  ----------  --------  ------  --- 
(2) Derivatives (other than options)          N/A 
-------------------------------------  ----------  --------  ------  --- 
(3) Options and agreements to 
 purchase/sell                                N/A 
-------------------------------------  ----------  --------  ------  --- 
Total                                  15,065,388  4.59557% 
-------------------------------------  ----------  --------  ------  --- 
 
 
   (b) Interests and short positions in relevant securities of the company, 
other than the class dealt in (Note 3) 
 
 
 
 
Class of relevant security:                     Long         Short 
-------------------------------------------  -----------  ----------- 
                                             Number  (%)  Number  (%) 
-------------------------------------------  ------  ---  ------  --- 
(1) Relevant securities                       N/A 
-------------------------------------------  ------  ---  ------  --- 
(2) Derivatives (other than options)          N/A 
-------------------------------------------  ------  ---  ------  --- 
(3) Options and agreements to purchase/sell   N/A 
-------------------------------------------  ------  ---  ------  --- 
Total                                         N/A 
-------------------------------------------  ------  ---  ------  --- 
 
 
   3. DEALINGS (Note 4) 
 
   (a) Purchases and sales 
 
 
 
 
Purchase/sale   Number of relevant securities  Price per unit (Note 5) 
--------------  -----------------------------  ----------------------- 
   Purchase                            11,000                   165.84 
--------------  -----------------------------  ----------------------- 
   Purchase                               100                   165.84 
--------------  -----------------------------  ----------------------- 
   Purchase                                63                   165.05 
--------------  -----------------------------  ----------------------- 
   Purchase                             3,515                   165.84 
--------------  -----------------------------  ----------------------- 
   Purchase                            76,818                   165.84 
--------------  -----------------------------  ----------------------- 
   Purchase                               387                   165.84 
--------------  -----------------------------  ----------------------- 
   Purchase                                21                   165.84 
--------------  -----------------------------  ----------------------- 
   Purchase                               116                   165.84 
--------------  -----------------------------  ----------------------- 
     Sale                                 100                   165.84 
--------------  -----------------------------  ----------------------- 
     Sale                               2,169                   165.84 
--------------  -----------------------------  ----------------------- 
     Sale                                 232                   165.84 
--------------  -----------------------------  ----------------------- 
 
 
   (b) Derivatives transactions (other than options transactions) 
 
 
 
 
Product name,  Nature of transaction  Number of relevant securities  Price per unit 
 e.g. CFD       (Note 6)               (Note 7)                       (Note 5) 
-------------  ---------------------  -----------------------------  -------------- 
N/A 
-------------  ---------------------  -----------------------------  -------------- 
 
 
 
   (c) Options transactions in respect of existing relevant securities 
 
   (i) Writing, selling, purchasing or varying 
 
 
 
 
Product name,      Writing, selling,  Number of             Exercise  Type, e.g.      Expiry  Option money 
 e.g. call option   purchasing         securities to which   price     American,       date    paid/received 
                    varying etc.       the option relates              European etc.           per unit (Note 5) 
                                       (Note 7) 
-----------------  -----------------  --------------------  --------  --------------  ------  ------------------ 
N/A 
-----------------  -----------------  --------------------  --------  --------------  ------  ------------------ 
 
 
   (ii) Exercising 
 
 
 
 
Product name,      Number of securities  Exercise price per 
 e.g. call option                           unit (Note 5) 
-----------------  --------------------  ------------------ 
N/A 
-----------------  --------------------  ------------------ 
 
 
   (d) Other dealings (including transactions in respect of new securities) 
(Note 4) 
 
 
 
 
Nature of transaction  Details       Price per unit 
 (Note 8)                        (if applicable) (Note 5) 
---------------------  -------  ------------------------- 
N/A 
---------------------  -------  ------------------------- 
 
 
   4. OTHER INFORMATION 
 
   Agreements, arrangements or understandings relating to options or 
derivatives 
 
 
 
 
Full details of any agreement, arrangement or understanding 
 between the person disclosing and any other person 
 relating to the voting rights of any relevant securities 
 under any option referred to on this form or relating 
 to the voting rights or future acquisition or disposal 
 of any relevant securities to which any derivative 
 referred to on this form is referenced. If none, this 
 should be stated. 
----------------------------------------------------------- 
N/A 
----------------------------------------------------------- 
 
 
 
 
 
 
Is a Supplemental Form 8 attached? (Note 9)                       NO 
-------------------------------------------------------  --------------------- 
Date of disclosure                                       12(th) September 2019 
-------------------------------------------------------  --------------------- 
Contact name                                                  Chetan Shah 
-------------------------------------------------------  --------------------- 
Telephone number                                                  020 33956564 
-------------------------------------------------------  --------------------- 
If a connected EFM, name of offeree/offeror with which   N/A 
 connected 
-------------------------------------------------------  --------------------- 
If a connected EFM, state nature of connection (Note     N/A 
 10) 
-------------------------------------------------------  --------------------- 
 
 
 
 
 
 

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ALLERGAN PLC
09/13ALLERGAN : Form 8.3 - Allergan Plc
DJ
09/12ALLERGAN : Form 8.3 -
DJ
09/11UPDATE : Form 8.3 - Allergan Plc (Correction of Doc)
DJ
09/11UPDATE : Form 8.3 - AbbVie Inc (Correction of Doc)
AQ
09/11UPDATE : Form 8.3 - Allergan plc (Correction of Doc)
AQ
09/11ALLERGAN PLC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
09/10ALLERGAN : Shareholder Meetings Scheduled for October 14, 2019
PU
09/10ALLERGAN : Form 8.3 - Allergan Plc
DJ
09/10ALLERGAN : and Molecular Partners Announce Acceptance of U.S. FDA Biologics Lice..
AQ
09/09ALLERGAN : Form 8.3 - Allergan Plc
DJ
More news